VBI Vaccines collaborates with the National Research Council of Canada to develop pan-coronavirus vaccine candidate

VBI Vaccines collaborates with the National Research Council of Canada to develop pan-coronavirus vaccine candidate

Source: 
Pharmaceutical Business Review
snippet: 


VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced a collaboration with the National Research Council of Canada (NRC), Canada’s largest federal research and development organization, to develop a pan-coronavirus vaccine candidate, targeting COVID-19, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS).